CMFlex
Commercial- Indications
- Facial bone reconstruction
Company intelligence / Profile preview
Dimension Inx
Chicago, Illinois, United Statesdimensioninx.com ↗
- Ownership
- Private
- Employees
- ~29
- Development stage
- Commercial
01
Overview
Successfully completed first clinical cases using CMFlex™, the first 3D-printed regenerative bone graft product cleared by the FDA. CMFlex received FDA 510(k) clearance for oral and maxillofacial indications.
- Therapeutic areas
- OtherRheumatology
- Modalities
- Biomaterials3D-printed therapeuticsRegenerative scaffolds
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Merz Biomaterials
Beyond the preview
Go deeper on Dimension Inx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dimension Inx.